openPR Logo
Press release

Novalung signs Carestream Medical, Inc., as exclusive distributor in Canada

04-21-2009 01:07 PM CET | Health & Medicine

Press release from: Novalung GmbH

Company intensifies its North American marketing activities to meet increasing demand in the Canadian market

Novalung GmbH, the German manufacturer of the innovative iLA Membrane Ventilator® for extrapulmonary lung support, is pleased to announce that it has appointed Carestream Medical, Inc., as its exclusive distributor in Canada. “Carestream is uniquely positioned to represent our products in the Canadian market”, said Dr. Georg Matheis, CEO of Novalung. “With their highly skilled team of respiratory-care specialists and their clinical expertise, they will be able to build on the Canadian experience with the iLA Membrane Ventilator® in lung transplant surgery and bring the benefits of extrapulmonary lung support to a much broader range of patients on mechanical ventilation.”

Shawn Nicol, National Sales Manager for Carestream Medical, said “We are thrilled to have added Novalung’s product line to our current range of leading-edge medical technologies. As respiratory therapists, we understand the benefit of advancing current ‘protective ventilation’ strategies towards true lung protection using the iLA Membrane Ventilator®.”

iLA Membrane Ventilator® has helped Canadian patients
In Canada, the iLA Membrane Ventilator® is currently best known for its successful role in treating patients at Toronto General Hospital and The Hospital for Sick Children as part of their lung transplantation programmes.

-------------

You can download high-resolution pictures as well as the literature compendium on www.novalung.com or it will be sent on request via email.

Please send us a copy of your imprint.

Background information on Novalung GmbH - Driver of a paradigm shift

Novalung is a German company which develops, produces and markets innovative solutions for lung failure, including the world’s first pumpless artificial lung assist device designed specifically to breathe outside the patient’s body. The iLA Membrane Ventilator® supports the lung by removing carbon dioxide directly from the blood, reducing the work load for the patient’s own lung. Use of the iLA Membrane Ventilator® thus permits adequate ventilation irrespective of lung function, and allows lung-protective parameters on the respirator to be used without the limitations usually imposed by the need for pulmonary gas exchange. The iLA Membrane Ventilator® is driven by the human heart like a natural organ, without the need for external blood pumps, and has been used to support patients’ lungs in over 4,000 cases of ARDS, ALI, pneumonia, exacerbated COPD, trauma and lung transplantation.

The iLA Membrane Ventilator® is connected non-surgically to a femoral (groin) artery and vein using two specially designed NovaPort® vascular access devices. The artificial lung itself measures only 14x14 cm. Inside, a hollow fibre membrane takes over the function of the pulmonary alveoli and thus supports or in some cases even replaces common mechanical ventilation. So-called “protective” ventilation strategies can now be pursued more aggressively; the patient’s natural lung is given „Time to Heal“®. The iLA Membrane Ventilator® is approved for temporary use up to 29 days for patients in intensive care units.

Background information on Carestream Medical, Inc.

Carestream Medical Ltd. was founded in 1997 and represents a broad range of respiratory-care, anesthesia and intensive-care products throughout Canada, with offices in Coquitlam (BC) and Pickering (ON). Carestream is in the top 200 of the fastest growing companies in Canada based on the previous five fiscal years.

Contact:

Franziska Preißing
Head of Marketing
franziska.preissing@novalung.com
Novalung GmbH
Egerten 3
D-74388 Talheim
Tel.: +49 7133 90 11 130
Fax: +49 7133 90 11 230
www.novalung.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Novalung signs Carestream Medical, Inc., as exclusive distributor in Canada here

News-ID: 76651 • Views: 1769

More Releases from Novalung GmbH

NovaPort twin, the Newest Double-Lumen Cannula, Approved
Novalung adds the unique double-lumen cannula to its expanding portfolio of products for the extrapulmonary treatment of lung failure. Now only a single cannula is required instead of two. Novalung announced today that it has received approval for the new NovaPort twin® double-lumen cannula, which is now available for clinical use. The NovaPort® twin cannula was specifically designed for veno-venous vascular access for the iLA activve® system - the Allrounder for
Novalung receives CE mark for iLA activve®
Novalung receives CE mark for iLA activve® With the new all-rounder for extrapulmonary lung support Novalung GmbH is the only company worldwide offering the complete portfolio for both pumpless and pump-driven lung support. Novalung announces receiving CE mark approval for their new pump-driven iLA activve® lung support system. It will be launched in Europe with immediate effect. Respiratory support with iLA activve® enables a treatment environment with awake, mobile patients instead
Novalung and Medos start cooperation
Due to the acquisition of Medos Medizintechnik AG by the private equity fund Zukunftsfonds Heilbronn (“Future Fund of Heilbronn”) the company will cooperate closely in the future with Novalung GmbH, which is expected to strengthen both medical device companies. The Zukunftsfonds Heilbronn (zfhn) announced that it has acquired Medos Medizintechnik AG from Ventizz Capital Partners Advisory AG. The purchase agreement was signed on January 7, 2011. With this
Josef Bogenschuetz joins Novalung as Managing Director
Novalung GmbH prepares for further growth with former Maquet CEO. As of January 1, 2011, Josef Bogenschütz and Dr. Georg Matheis are joint Managing Directors of Novalung GmbH. Bogenschütz will be specifically responsible for Research & Development, Manufacturing, Quality Management and Finance. This addition underscores the company’s focus on the ongoing and efficient expansion of its portfolio of innovative products designed to replace invasive mechanical ventilation. Nicholas L. Strout remains responsible

All 5 Releases


More Releases for Membrane

Membrane Bioreactor Market 2017-2023 | Key Players GE Water and Process Technolo …
The membrane bioreactor is the technology for wastewater treatment industries, which is witnessing greater adoption in the global market. The market includes the study of various types of configurations, products, applications and geographic analysis. The membrane bioreactor technology is more advanced than conventionally activated sludge method of wastewater management. The technology is efficient due to lower operational and maintenance cost. The market is driven due to increased utilization of the
Membrane Microfiltration Market 2018 - 2028 | By Membrane Type ( PES Membrane F …
Membrane Microfiltration Market: Value and Forecast The global membrane microfiltration market is expected to expand at a CAGR of 7.8% in revenue terms over the forecast period 2018–2028. The global membrane microfiltration market is expected to be dominated by Western Europe with a 22.3% revenue share in 2018. Membrane Microfiltration Market: Product Outlook In water treatment systems, microfiltration membranes help in removing small particles and solids such as iron (rust), manganese (rust), clay, silt and
Membrane Technology Market | Market Growth Analysis 2019
Transparency Market Research (TMR) has recently published a market study on the global membrane technology market, projecting the market to exhibit a CAGR of 9.10% during the period from 2014 to 2019 and reach a market value of US$10.8 bn by the end of the forecast period.The report, titled “Membrane Technology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2019”, states that the worldwide membrane
Breathable Membrane Market : Industry Analysis 2024
Breathable membranes are semi-porous films or sheets, which allow the exchange of water vapor while preventing liquid water from permeating through. These membranes prevent water from seeping into the roof structure, while providing cold and warm ventilation. Breathable membranes are primarily used in the building & construction industry; they are used as underlay for various types of roofs such as slated pitched roofs and tiled roofs. Large amount of water
United States Photosensory Membrane Market Report 2017
Summary This report studies sales (consumption) of Photosensory Membrane in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Company 1 Company 2 Company 3 Company 4 Company 5 Company 6 Company 7 Market Segment by States, covering California Texas New York Florida Illinois Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Split by applications, this report focuses on sales, market share
Global Membrane Switches Sales Market Report 2017
This report studies sales (consumption) of Membrane Switches in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Molex(US) XYMOX(US) Douglas Corporation(US) Fujikura(JP) Human E&C(KOR) Human E&C(KOR)